EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biotricity's enterprise value is $36.69 Mil.
Biotricity's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $11.63 Mil. Therefore, Biotricity's EV-to-Revenue for today is 3.16.
The historical rank and industry rank for Biotricity's EV-to-Revenue or its related term are showing as below:
BTCY'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.63 Med: 23.66 Max: 5206.24
Current: 3.16
During the past 10 years, the highest EV-to-Revenue of Biotricity was 5206.24. The lowest was 2.63. And the median was 23.66.
BTCY's EV-to-Revenue is ranked worse than 51.52% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 3.07
vs BTCY: 3.16
As of today (2024-04-26), Biotricity's stock price is $1.30.
Biotricity's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.32. Therefore, Biotricity's PS Ratio for today is 0.99.
Biotricity EV-to-Revenue Historical Data
The historical data trend for Biotricity's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biotricity's EV-to-Revenue
For the Medical Devices subindustry, Biotricity's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotricity's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Biotricity's EV-to-Revenue falls into.
Biotricity's current Enterprise Value is $36.69 Mil.
Biotricity's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotricity's share price for today is $1.30.
Biotricity's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotricity EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Biotricity's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed, which is a virtual clinic platform that enables clinicians to provide outstanding patient care remotely; Bioheart, which is a personal heart monitor; and Biocare health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BTCY has been successfully added to your 